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Impaired Left Ventricular Stroke Volume
Reserve During Clinical Dobutamine Stress
Predicts Future Episodes of Pulmonary Edema
Charaslak Charoenpanichkit, MD,* William C. Little, MD,* Sangeeta Mandapaka, MD,*
Erica Dall’Armellina, MD,* Timothy M. Morgan, PHD,† Craig A. Hamilton, PHD,‡
W. Gregory Hundley, MD*§
Winston-Salem, North Carolina
Objectives The purpose of this study was to determine whether dobutamine-induced abnormal stress changes in left ven-
tricular stroke volume (LVSV) and aortic stiffness predict future pulmonary edema.
Background Increased aortic stiffness that decreases LVSV during adrenergic stress may serve as a marker for future pulmo-
nary edema (PE).
Methods We measured LVSV, ventriculovascular stiffness (pulse pressure/LVSVindex), and aortic distensibility at rest and
during intravenous dobutamine administration using cardiovascular magnetic resonance. Personnel blinded to
dobutamine cardiovascular magnetic resonance followed participants longitudinally over time to identify those
admitted to the hospital with PE. Data for 44 participants who had a hospital admission for PE were compared
with data for 72 participants of similar age, sex, and resting left ventricular ejection fraction who remained PE free.
Results Expressed as median and interquartile range, participants with and without PE exhibited a decreased stress/rest
LVSV ratio (0.9 [range 0.7 to 1.1] vs. 1.0 [range 0.9 to 1.2], respectively; p  0.002), an increased ventriculovas-
cular stiffness stress/rest ratio (1.4 [range 1.0 to 1.6] vs. 1.0 [range 0.8 to 1.3], respectively; p  0.001); and a
decreased stress-induced measure of aortic distensibility (0.8 mm Hg3 [range 0.3 to 1.3 mm Hg3] vs. 1.6 mm Hg3
[range 1.2 to 3.2 mm Hg3], respectively; p  0.002). After accounting for age, sex, left ventricular ejection frac-
tion, risk factors for PE, and the presence of dobutamine-induced ischemia, LVSV reserve and the stress/rest
ventriculovascular stiffness ratio still differed (p  0.008 for both) in those with and without PE.
Conclusions In patients without inducible ischemia during dobutamine stress testing in whom one might otherwise assume a
favorable prognosis, the failure to increase LVSV or an increase in ventriculovascular stiffness indicates patients
at risk of subsequent PE. (J Am Coll Cardiol 2011;57:839–48) © 2011 by the American College of Cardiology
Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.10.019Acute myocardial ischemia or myocardial infarction (MI)
may limit the ability of the left ventricle to augment its
stroke volume in response to stress (1). In this situation, the
right ventricle may displace blood into the lungs, increase
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2010, accepted October 12, 2010.left atrial pressure, and produce pulmonary edema (PE)
(2,3). The onset of PE (often accompanied by arterial
hypertension) can occur in the absence of a decrease in left
ventricular ejection fraction (LVEF) or with the develop-
ment of new regional wall motion abnormalities (4). As
shown by Kawaguchi et al. (5), increased vascular stiffness can
adversely affect left ventricular (LV) performance in patients
with PE who do not exhibit myocardial ischemia (5).
Accordingly, we hypothesized that in the absence of
ischemia, an inability of the left ventricle to increase stroke
volume due to an abnormal increase in arterial stiffness may
predispose patients to the future development of PE. To
evaluate this hypothesis, we measured stress/rest left ven-
tricular stroke volume (LVSV), ventriculovascular stiffness
(pulse pressure [PP]/LVSV index [LVSVi] for body surface
area), and aortic distensibility during administration of
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tients in whom PE subsequently
developed. We compared their
data with data for a group of
individuals who also underwent
dobutamine stress testing but in
whom PE did not develop. Strat-
ified analyses were performed to
address the association of LVSV
with future PE in participants
with and without dobutamine-
induced LV wall motion abnor-
malities indicative of ischemia.
Methods
Study design and population.
The Institutional Review Board of
the Wake Forest University
School of Medicine approved the study, including the review
of medical records. In addition, study participants provided
informed consent for the dobutamine stress imaging procedure
and post-testing analysis of the imaging data. We used a study
design in which participants experiencing PE were selected
from a patient population that previously (1 month) had
ndergone dobutamine cardiovascular magnetic resonance
DCMR) stress testing. From 362 DCMR stress examinations
hat were consecutively performed between April 1997 and
pril 2003, we identified all 44 individuals who subsequently
Abbreviations
and Acronyms
DCMR  dobutamine
cardiovascular magnetic
resonance
LV  left ventricular
LVEDV  left ventricular
end-diastolic volume
LVSV  left ventricular
stroke volume
LVSVi  left ventricular
stroke volume index
MI  myocardial infarction
PE  pulmonary edema
PP  pulse pressure
SBP  systolic blood
pressure
Figure 1 Study Population
Diagram segregating participants receiving dobutamine cardiac magnetic resonanc
and an age,- sex-, and resting left ventricular ejection fraction–matched distributioere hospitalized for PE over a 6-year follow-up period at our
edical center. PE was defined as an acute onset of dyspnea in
he presence of rales on physical examination recorded by the
anaging physician, evidence of pulmonary congestion on the
hest radiograph, and subsequent receipt of intravenous di-
retic therapy to relieve pulmonary congestion. This definition
as commensurate with selection of criteria used to adjudicate
E due to heart failure in the I-PRESERVE (Irbesartan in
eart Failure with Preserved Ejection Fraction) study (6).
atients with lung cancer or moderate to severe valvular heart
iseases were excluded from analyses. Our comparison popu-
ation was selected from the same 362 individuals who had
ndergone a DCMR stress examination and in whom future
E did not develop in the same follow-up time frame (Fig. 1).
linded to the cardiac and vascular imaging study results,
ubjects in the control group were selected to have a distribu-
ion of sex, age, and resting LVEF similar to that of the 44
ndividuals who experienced PE.
Personnel performing analyses were blinded to other
spects of the study. For example, those unaware of stress
esting results reviewed the medical charts to identify PE
utcomes of the participants. Likewise, those assessing
CMR stress data were blinded to participant outcomes.
obutamine/atropine cardiac magnetic resonance protocol.
mages were acquired with a 1.5-T Horizon (General
lectric Medical Systems, Milwaukee, Wisconsin) whole-
ody imaging system using a phased-array cardiac surface
oil according to previously published techniques (7,8).
ss testing in whom pulmonary edema developed (n  44)
rticipants (n  72) in whom pulmonary edema did not develop.e stre
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mcg/kg/min) to high dose (20 to 40 mcg/kg/min), and
atropine was infused (up to 1.5 mg) to achieve 85% of the
maximum predicted heart rate response for age, the heart rate
response associated with a maximal test (7,8). Images were
acquired at rest, at low- and high-dose infusion, and then after
10 min of recovery (7,8). K-space segmentation was adjusted to
achieve a temporal resolution of 20 ms for determining LV
end-systolic dimensions at peak stress.
Image analysis. LV volumes were determined according to
previously published techniques using a biplane area-length
technique (8–10) from the 4- and 2-chamber views of the left
ventricle. Cardiovascular stiffness was assessed using previously
published methods using measurements of aortic distensibility
(11) and the brachial PP/LVSVi (12). Aortic distensibility was
efined as the maximum aortic area  the minimum aortic
rea  minimum aortic area  brachial PP (13,14).
tatistical analysis. Categorized data were summarized by
ercentages. Because many of the continuous data were
kewed, the central value and spread of the distribution of
alues are presented as the median and interquartile range
IQR). When box-and-whisker plots were given, the box
emonstrated the 25th, 50th, and 75th percentiles, and the
hiskers represented the largest values within 1.5 times the
nterquartile range from the median. Comparison of pro-
ortions between groups was tested for significance using
he Fisher exact test.
The association between measures was estimated and
ested using Spearman’s rank correlation. Comparison of
ontinuous data between groups was tested for significance
sing the Wilcoxon rank sum test. Comparisons of change
n measures during the stress test were tested for significance
sing the Wilcoxon rank test for paired comparisons.
nalysis of covariance, in which other factors are included
n the model, was conducted using rank-based nonparamet-
ic methods. The estimates and tests of the association of
ncreased risk of PE by DCMR data were estimated and
ested for significance using Cox’s proportional hazards
odel for case-control studies (15). The estimate of group
ffect was made after controlling for known risk factors of
E (age, sex, diabetes, hypertension, previous coronary
rtery revascularization or MI, body mass index). The
tatistical comparisons were 2 tailed, and p values 0.05
ere considered statistically significant.
esults
he average follow-up times for those with and without
uture PE were similar (6  2 years and 6  2 years,
respectively; p  0.41). Isolated PE occurred in 29 cases; in
ther cases, PE occurred along with MI (n 4), acute renal
ailure (n  3), post-operatively (n  3), during atrial
brillation with a rapid ventricular response (n  3), after
hemotherapy (n  1), and after cardiac arrest (n  1). As
hown in Figure 1, we performed analyses on our entiretudy population and additional stratified analyses on only
hose with isolated PE.
Demographic data of the study participants are shown in
able 1. The age and sex of both the participant groups
ere similar. Patients with future PE exhibited more
iabetes, but the prevalence of hypertension, a history of
I, hypercholesterolemia, smoking, and medication use
ere similar between the groups. Body mass index trended
igher in the PE participants.
Hemodynamic data from the subjects’ dobutamine studies
re also shown in Table 1. Those with future PE received 20
g/kg/min (IQR: 20 to 30 g/kg/min) dobutamine and 0 mg
(IQR: 0.0 to 0.3 mg) atropine, and those without future PE
received 20 g/kg/min (IQR: 20 to 30 g/kg/min) dobut-
mine and 0 mg (IQR: 0.0 to 0.3 mg) atropine during testing
p  0.51 and 0.64, respectively). Participants without future
E exhibited higher peak stress heart rate responses than those
ith PE (p  0.02).
LV volumes, LVEF, cardiac output, and vascular stiffness
ata are shown in Table 2. Patients with PE had a higher
revalence of dobutamine-induced LV wall motion abnor-
alities indicative of ischemia (63% vs. 32%, p  0.001).
est measures of LV volumes, LVEF, and ventriculovascu-
ar stiffness were similar in both groups. At peak stress, left
entricular end-diastolic volume (LVEDV) was similar in
hose with and without PE (101 ml [range 79 to 154 ml] vs.
04 ml [range 73 to 122 ml], p 0.29), the LV end-systolic
olume was lower in those without versus those with PE (41
l [range 29 to 61 ml] vs. 58 ml [range 43 to 97 ml],
espectively; p  0.007). Those without versus those with PE
xhibited higher LVSV reserve measurements (1.0 [range 0.9
o 1.5] vs. 0.9 [range 0.7 to 1.0], respectively, p 0.002) (Fig. 2).
fter adjustment for age, sex, diabetes, hypertension, pre-
ious coronary artery revascularization, body mass index,
nd previous MI, LVSV reserve (stress/rest LVSV) still
iffered in those with and without future PE (p  0.002).
articipants with an LVSV reserve of 1.0 were 50% more
ikely to experience PE (p  0.001) than those with an
VSV reserve 1.0.
Measures of total vascular stiffness (PP/LVSVi) were
similar between the groups at rest. At peak stress, those with
PE exhibited an increased PP/LVSVi (2.8 [range 2.2 to 4.3]
vs. 2.5 [range 1.9 to 3.3], respectively; p  0.04), and
stress/rest ratios of PP/LVSVi (1.4 [range 1.0 to 1.6] vs. 1.0
[range 0.8 to 1.3], respectively; p  0.001). As shown in
Table 2 and Figure 2B, the stress/rest ratios of PP/LVSVi
were higher, whereas stress-induced aortic distensibility was
lower in participants with versus those without future PE.
Stratified analyses were performed in participants without
inducible LV ischemia during dobutamine stress testing. As
displayed in Figure 1 and Table 3, there were 12 subjects
with isolated PE and no ischemia during dobutamine-
induced stress. These 12 subjects were compared with the
49 subjects without PE who also had no inducible ischemia
during dobutamine-induced stress. In these analyses, those
with versus those without PE exhibited impaired LVSV
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Impaired LV Stroke Volume and Pulmonary Edema February 15, 2011:839–48reserve (p 0.02) (Fig. 3A) and a decrease in stress-induced
aortic distensibility (p  0.01) (Fig. 3B). Importantly, after
adjustment for demographic and historical comorbidities
associated with the future risk of PE, stress/rest ratios of
LVSV reserve (p  0.03), cardiovascular stiffness (p 
0.02), and stress aortic distensibility (p  0.05) remained
significantly different in those with versus those without PE.
Because we wanted to identify associations of our DCMR
measures with PE in individuals with a preserved LVEF
(often termed heart failure and preserved LVEF), we
performed additional stratified analyses on the 59 partici-
pants with an LVEF 50% and found that the 18 partic-
ipants with PE exhibited a lower LVSV reserve (0.9 [range
0.7 to 0.9] vs. 1.0 [range 0.9 to 1.1], p  0.001), a higher
tress/rest ratio of PP/LVSV (1.4 [range 1.0 to 1.7] vs. 1.1
range 0.8 to 1.3], p  0.02), and a trend toward a lower
tress-induced aortic distensibility (0.8 [range 0.3 to 0.9] vs.
.3 [range 0.8 to 2.7], p  0.08) than the 41 individuals
ithout future PE. Sixteen participants with an LVEF
50% exhibited inducible LV wall motion abnormalities
ndicative of ischemia. When we analyzed only the partic-
pants with an LVEF 50% and no inducible LV wall
Baseline Characteristic of Participants With and Without PulmonarTable 1 Baseline Characteristic of Participants With and Witho
All (n  116)
Demographics
Age, yrs 67 (60–74)
Sex, male 54
Body mass index, kg/m2 29 (26–34)
Historical data
Previous myocardial infarction 42
Hypertension 72
Diabetes mellitus 36
Hypercholesterolemia 57
Smoking 41
Medications
Beta-blocker 40
Calcium-channel blocker 30
Nitrate 28
ACE inhibitor/ARB 37
Statin 30
Resting pulse pressure, mm Hg 63 (50–74)
Resting heart rate, beats/min 72 (64–81)
Resting SBP, mm Hg 137 (124–154)
Resting DBP, mm Hg 76 (66–86)
Stress pulse pressure, mm Hg 71 (56–88)
Stress heart rate, beats/min 130 (119–135)
% MPHR 85 (79–87)
Stress SBP, mm Hg 144 (126–168)
Stress DBP, mm Hg 73 (65–85)
Stress/resting pulse pressure 10 (6–21)
Dobutamine, mcg/kg/min 20 (20–30)
Atropine, mg 0 (0–0.4)
Values are expressed as median (interquartile range) or %.
ACE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker; DBP  diastolic blotion abnormalities indicative of ischemia, the results temonstrated that LVSV reserve and stress/rest ratios of
P/LVSV stiffness remained different in those with and
ithout future PE (p  0.02 and 0.04, respectively).
Overall, LVEDV decreased by 10 ml (range 1 to 19 ml)
rom rest to peak stress (p  0.001) with a 12-ml (range 1
o 20 ml) versus 7-ml (range 1 to 16 ml) decrease in those
ithout versus those with PE, respectively (p  0.20).
here was a small correlation of 0.30 (p  0.001) between
VSV reserve and change in LVEDV. Systolic blood
ressure (SBP) and PP increased 8 mm Hg (range 8 to
3 mm Hg) and 10 mm Hg (6 to 21 mm Hg),
espectively (p  0.001 for both) for all participants, with
1% of the participants having an increase in their SBP
uring the stress test. For the participants without versus
hose with PE, SBP increased by 5 mm Hg (range 10 to
2 mm Hg) and 14 mm Hg (range 1 to 23 mm Hg),
espectively (p  0.19 for the difference), and PP increased
y 4 mm Hg (range 8 to 19 mm Hg) and 12 mm Hg
range 1 to 23 mm Hg), respectively (p  0.08 for the
ifference). For those without ischemia during testing, SBP
ncreased in subjects without versus those with PE by 1
m Hg (range 10 to 14 mm Hg) and 9 mm Hg (range 1
maulmonary Edema
Pulmonary Edema
p ValueYes (n  44) No (n  72)
68 (60–76) 67 (59–73) 0.60
52 55 0.85
30 (27–35) 29 (25–32) 0.13
48 39 0.44
70 72 0.84
48 29 0.05
59 55 0.85
48 36 0.25
39 42 0.85
36 26 0.30
36 22 0.14
43 33 0.33
32 43 0.83
62 (47–77) 63 (51–74) 0.52
69 (64–82) 74 (65–81) 0.49
134(121–153) 139 (126–159) 0.37
74 (65–84) 76 (66–87) 0.25
70 (54–88) 71 (59–86) 0.66
125 (105–131) 130 (120–135) 0.02
84 (67–86) 85 (81–88) 0.01
143 (128–168) 144 (126–169) 0.91
70 (63–81) 74 (65–86) 0.18
12 (2–23) 5 (8–19) 0.08
20 (20–30) 20 (20–30) 0.51
0 (0–0.4) 0 (0–0.3) 0.64
ssure; MPHR  maximum predicted heart rate response for age; SBP  systolic blood pressure.y Edeut Po 21 mm Hg), respectively (p  0.12 for the difference) in
s
a
; EDV 
v se pres
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increased by 3 mm Hg (range 10 to 16 mm Hg) and 10
mm Hg (range 1 to 25 mm Hg), respectively (p  0.05 for
the difference) in those without versus those with future PE.
Discussion
The results of this study indicate that 1) impaired augmen-
tation of LVSV during dobutamine stress testing may serve
as a marker for the future development of PE: an LVSV
reserve of 1 was associated with a twofold increase in the
risk of future PE relative to those with an LVSV reserve1;
2) a decreased LVSV reserve was associated with PE
independent of age, sex, LVEF, inducible LV wall motion
abnormalities, and other risk factors for PE or congestive
heart failure (p  0.002); and 3) an increase in the
tress/resting ratio of ventriculovascular stiffness (measured
s brachial PP/LVSVi for body surface area or stress-
induced aortic distensibility) was associated with future PE
in the absence of dobutamine-induced LV wall motion
DCMR Findings in Participants With and Without Pulmonary EdemaTable 2 DCMR Findings in Participants With and Without Pulm
All (n  116)
Resting EF 50 (40 to 55)
Resting EDV 110 (91 to 147)
Resting ESV 59 (43 to 83)
Resting SV 52 (41 to 63)
Stress EDV 103 (76 to 134)
Stress ESV 46 (31 to 75)
Stress SV 54 (41 to 62)
Resting EDVi 55 (45 to 73)
Resting ESVi 29 (16 to 35)
Resting SVi 26 (21 to 32)
Stress EDVi 52 (40 to 65)
Stress ESVi 24 (16 to 35)
Stress SVi 26 (21 to 32)
Resting PP/SV 1.2 (0.9 to 1.7)
Resting PP/SVi 2.5 (1.8 to 3.2)
Stress PP/SV 1.3 (1.0 to 1.7)
Stress PP/SVi 2.6 (2.0 to 3.7)
Stress/resting SV 0.6 (6.5 to 6.7) 
Stress/resting SVi 0.3 (3.3 to 3.4) 
Stress-resting PP/SV 0.1 (0.2 to 0.5)
Stress/resting PP/SVi 0.2 (0.4 to 0.9)
Stress/resting PP/SV 1.1 (0.8 to 1.5)
Rest CO 3.6 (3.0 to 4.8)
Stress CO 6.7 (4.9 to 7.7)
Stress/resting CO 1.7 (1.4 to 2.1)
Resting CI 1.8 (1.5 to 2.4)
Stress CI 3.2 (2.6 to 3.9)
Stress-rest CO 2.6 (1.9 to 3.9)
Stress-rest CI 1.3 (0.7 to 1.9)
Values are expressed as median (interquartile range).
CI  cardiac index; CO  cardiac output; DCMR  dobutamine cardiovascular magnetic resonance
olume; ESVi  end-systolic volume index; PP/SV  pulse pressure/stroke volume; PP/SVi  pulabnormalities indicative of ischemia. This increase in car-diovascular stiffening during intravenous dobutamine stress
testing may contribute to the mechanism by which LVSV
could be limited during stress in the absence of inducible
LV wall motion abnormalities indicative of ischemia.
PE can occur in individuals with either a decreased or
preserved LVEF (4,16,17). To this end, we assessed indi-
viduals with an LVEF ranging from 33% to 77% and found
that impaired LVSV reserve during dobutamine-induced
stress was associated with future PE in those with an LVEF
50% or 50% (p  0.002). To address whether inducible
LV wall motion abnormalities observed during dobutamine-
induced stress accounted for the decrease in LVSV reserve,
we performed stratified analyses (Table 3) in individuals
without dobutamine-induced LV wall motion abnormalities
indicative of ischemia. In those participants without induc-
ible LV wall motion abnormalities indicative of ischemia
during dobutamine-induced stress, impaired augmentation
of the LVSV reserve remained associated with PE com-
pared with controls (p  0.02) (Fig. 3). Importantly, the
results of these stratified analyses indicate that impaired
Edema
Pulmonary Edema
p Value(n  44) No (n  2)
6 to 54) 52 (44 to 55) 0.08
9 to 179) 109 (91 to 131) 0.43
2 to 114) 57 (43 to 72) 0.38
7 to 72) 51 (44 to 58) 0.61
9 to 154) 104 (73 to 122) 0.29
3 to 97) 41 (29 to 61) 0.007
4 to 58) 55 (48 to 65) 0.02
3 to 87) 54 (46 to 70) 0.68
1 to 54) 29 (23 to 38) 0.56
9 to 34) 25 (21 to 31) 0.77
0 to 78) 52 (40 to 61) 0.41
1 to 48) 22 (15 to 32) 0.02
7 to 31) 27 (24 to 33) 0.02
.8 to 1.8) 1.2 (0.9 to 1.5) 0.56
.7 to 3.5) 2.5 (1.9 to 3.0) 0.63
.1 to 2.3) 1.3 (1.0 to 1.6) 0.04
.2 to 4.3) 2.5 (1.9 to 3.3) 0.04
12.5 to 2.5) 1.5 (5.2 to 8.9) 0.002
6.0 to 1.3) 0.7 (2.7 to 4.2) 0.002
0.0 to 0.8) 0.0 (0.2 to 0.3) 0.001
0.0 to 1.4) 0.0 (0.5 to 0.6) 0.001
.0 to 1.6) 1.0 (0.8 to 1.3) 0.001
.5 to 5.1) 3.6 (3.0 to 4.6) 0.69
.1 to 7.2) 7.0 (5.9 to 7.8) 0.002
.2 to 1.8) 1.9 (1.5 to 2.2) 0.001
.5 to 2.5) 1.8 (1.4 to 2.4) 0.89
.0 to 3.7) 3.4 (2.8 to 4.1) 0.001
.9 to 2.9) 3.0 (2.2 to 4.2) 0.001
.4 to 1.4) 1.5 (1.1 to 2.1) 0.001
end-diastolic volume; EDVi  end-diastolic volume index; EF  ejection fraction; ESV  end-systolic
sure/stroke volume index; SV  stroke volume; SVi  stroke volume index.onary
Yes
48 (3
116 (8
66 (4
54 (3
101 (7
58 (4
47 (3
57 (4
31 (2
27 (1
53 (4
26 (2
23 (1
1.1 (0
2.3 (1
1.5 (1
2.8 (2
3.7 (
2.1 (
0.3 (
0.6 (
1.4 (1
3.7 (2
5.3 (4
1.4 (1
1.9 (1
2.8 (2
1.6 (0
0.7 (0LVSV reserve serves as a marker for future PE in the
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Impaired LV Stroke Volume and Pulmonary Edema February 15, 2011:839–48absence of conventional clinical markers of inducible isch-
emia used during dobutamine-induced stress.
Although our participants with PE exhibited a greater
frequency of diabetes and hypertension, LVSV reserve
was associated with PE independent of the presence of
these conditions (p  0.001). We recognize that clinical
conditions such as renal failure, acute MI, chemotherapy-
Figure 2 Left Ventricular SV and Aortic Stiffness (All)
Box-and-whisker plots of stress/rest left ventricular stroke volume (SV) (y-axis) (A)
vascular magnetic resonance imaging. Pulmonary edema–negative and –positive g
and stress-induced aortic stiffness was increased in pulmonary edema–positive pa
bottom lines of the boxes represent the 25th and 75th percentiles, respectively;
that is 1 to 1.5 quartile of the interquartile range and the largest data value thainduced cardiomyopathy, valvular heart disease, and lungcancer may cause individuals to experience PE due to
established causes. However, our analyses demonstrated
that limits of LVSV reserve as well as increased ventricu-
lovascular and aortic stiffness were predictive of future PE
in the presence or absence of these conditions. In
addition, a DCMR LVSV reserve of 1 was highly
predictive of those who would remain PE free 2 years
eak stress aortic distensibility (y-axis) (B) measured during dobutamine cardio-
are shown on the x-axis. Left ventricular stroke volume reserve was decreased
nts. In these plots, lines within boxes represent median values; the top and
e top and bottom whiskers outside the boxes represent the smallest data value
 1.5 quartile of the interquartile range, respectively.and p
roups
rticipa
and th
t is 3after stress testing.
nd-dias
i  stro
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February 15, 2011:839–48 Impaired LV Stroke Volume and Pulmonary EdemaWhy would decreased LVSV reserve serve as a marker for
future PE? In patients with normal cardiovascular perfor-
mance, cardiac output increases during stress due to an
increase in heart rate, enhanced venous return to the right
heart due to recruitment of blood from peripheral veins, and
an increase in LVSV due to a decrease in LV end-systolic
volume and maintenance or increase in LVEDV (18). We
found that patients in whom acute PE subsequently devel-
oped had a decreased ability to increase LVSV in response
to pharmacologic stress. In this study, we do not have
information regarding right ventricular stroke volume; how-
ever, if LVSV failed to increase during exercise or volume
challenge, an increase in right ventricular stroke volume
could result in displacement of blood into the lungs, increase
in left atrial pressure, and the development of PE (19–21).
It is important to note that we used dobutamine-induced
stress rather than exercise to induce cardiovascular stress.
We selected intravenous dobutamine because of its ease of
clinical implementation, and one can collect images for
measuring LV volumes simultaneously with the intravenous
infusion. The stress produced by dobutamine-induced stress
differs from exercise in 2 major respects (22). First, walking,
running, or biking stimulates lower extremity muscle con-
traction and facilitates recruitment of venous blood into the
central circulation. This, in turn, increases right ventricular
DCMR Findings in Participants With and Without Isolated PulmonaTable 3 DCMR Findings in Participants With and Without Isola
All (n  61)
Pulmonary Edem
Yes (n  12) N
Resting EF 53 (45 to 56) 51 (41 to 54) 5
Resting EDV 109 (92 to 126) 113 (96 to 162) 10
Resting ESV 57 (43 to 72) 66 (37 to 113) 5
Resting SV 51 (44 to 58) 55 (46 to 61) 5
Stress EDV 99 (76 to 116) 110 (95 to 140) 9
Stress ESV 42 (30 to 61) 63 (44 to 101) 4
Stress SV 55 (47 to 59) 50 (35 to 58) 5
Resting EDVi 53 (45 to 69) 58 (47 to 90) 5
Resting ESVi 28 (22 to 38) 32 (20 to 63) 2
Resting SVi 25 (21 to 30) 30 (21 to 33) 2
Stress EDVi 50 (40 to 60) 59 (44 to 78) 5
Stress ESVi 23 (16 to 31) 29 (22 to 55) 2
Stress SVi 26 (23 to 31) 23 (18 to 31) 2
Resting PP/SV 1.2 (0.9 to 1.7) 1.1 (0.9 to 1.8) 1.
Resting PP/SVi 2.6 (1.9 to 3.2) 2.4 (1.7 to 3.3) 2.
Stress PP/SV 1.3 (1.0 to 1.6) 1.4 (1.2 to 2.1) 1.
Stress PP/SVi 2.5 (2.0 to 3.3) 2.8 (2.4 to 4.0) 2.
Stress/resting SV 1.3 (1.0 to 1.6) 0.9 (0.7 to 1.1) 1.
Stress/resting SV 1.3 (5.6 to 6.5) 3.0 (16.2 to 2.2) 1.
Stress/resting SVi 0.6 (3.0 to 3.3) 1.6 (7.5 to 1.3) 0.
Stress-resting PP/SV 0.0 (0.2 to 0.3) 0.5 (0.1 to 0.8) 0.
Stress/resting PP/SVi 0.0 (0.5 to 0.7) 0.8 (0.3 to 1.6) 0.
Stress/resting PP/SV 1.0 (0.8 to 1.3) 1.4 (1.1 to 1.6) 0.
Values are expressed as median (interquartile range). *Factors included in the multivariate mode
hypercholesterolemia, and smoking.
DCMR dobutamine cardiovascular magnetic resonance; EDV end-diastolic volume; EDVi e
ndex; PP/SV  pulse pressure/stroke volume; PP/SVi  pulse pressure/stroke volume index; SVend-diastolic volume and LVEDV (23). Intravenous do-butamine does not produce this effect, and, as shown in
Table 2, we did not see maintenance or an increase in
LVEDV in our subjects. In fact, LVEDV decreased in our
participants, and thus the majority of our differences in
LVSV reserve were due to differences in stress-induced
change in LVEDV. We note, however, that our study was
not powered to identify differences in the LVEDV with
stress in those with and without PE, and although the SD
change in LVEDV with stress was large in the study, it is
interesting that the median change in LVEDV was 12 ml
versus 7 ml in those without as opposed to those with PE
(p  0.20). Perhaps a study of more participants would
identify an association of stress-induced change in LVEDV
and future pulmonary disease.
Second, intravenous dobutamine relaxes arterial tone,
which is often manifest by a decrease in SBP during initial
infusions of the drug (24). Exercise, however, often in-
creases SBP (25) and in patients with noncompliant vascu-
lature can increase SBP further (19,21). Both our group and
others have shown that proximal aortic distensibility is
decreased in patients with heart failure with or without a
decreased LVEF. In participants without inducible LV wall
motion abnormalities, there was a strong trend (p  0.08)
toward an increase in PP (a surrogate for aortic stiffness) in
patients with (12 mm Hg) versus those without (4 mm Hg)
ema and No Inducible Ischemiaulmonary Edema and No Inducible Ischemia
p Value
p Value
49) Adjusted for Age, Sex Adjusted for All Factors*
o 56) 0.10 0.02 0.01
o 125) 0.26 0.09 0.10
o 69) 0.53 0.24 0.27
o 55) 0.23 0.11 0.10
o 113) 0.10 0.16 0.07
o 58) 0.008 0.005 0.007
o 59) 0.18 0.28 0.22
o 66) 0.32 0.21 0.16
o 35) 0.64 0.42 0.40
o 30) 0.42 0.45 0.30
o 58) 0.15 0.15 0.12
o 28) 0.02 0.02 0.02
o 31) 0.21 0.21 0.21
to 1.7) 0.67 0.34 0.28
to 3.2) 0.68 0.41 0.31
to 1.6) 0.06 0.15 0.31
to 3.2) 0.10 0.28 0.39
to 1.2) 0.04 0.06 0.07
0 to 7.9) 0.009 0.04 0.05
8 to 4.0) 0.04 0.06 0.08
6 to 0.5) 0.004 0.01 0.02
6 to 0.5) 0.003 0.008 0.01
to 1.2) 0.002 0.004 0.008
e, sex (male), body mass index, previous myocardial infarction, hypertension, diabetes mellitus,
tolic volume index; EF ejection fraction; ESV end-systolic volume; ESVi end-systolic volume
ke volume; SVi  stroke volume index.ry Edted P
a
o (n 
4 (47 t
7 (91 t
7 (43 t
0 (44 t
9 (73 t
0 (28 t
5 (49 t
2 (45 t
8 (22 t
5 (21 t
0 (40 t
0 (15 t
6 (25 t
2 (1.0
6 (2.1
2 (0.9
5 (1.9
0 (0.9
5 (5.
8 (2.
1 (0.
2 (0.
9 (0.8
l are agfuture PE. Although intravenous dobutamine may not
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afterload) to the same degree as exercise, our data demon-
strate that the failure to increase LVSV during dobutamine
infusion is associated with future pulmonary congestion.
Why was LVSV impaired during intravenous dobut-
amine infusion? Functionally apparent myocardial ischemia
Figure 3 Left Ventricular Stroke Volume and Aortic Stiffness (I
Box-and-whisker plots of stress/resting left ventricular stroke volume (y-axis) (A) a
cular magnetic resonance imaging. Pulmonary edema–negative and –positive grou
inducible left ventricular wall motion abnormalities indicative of ischemia during do
stress-induced aortic distensibility was increased relative to control subjects. In th
the boxes represent the 25th and 75th percentiles, respectively; and the top and
1.5 quartile (interquartile range) and the largest data value that is 3  1.5 quarwas not the cause of those with PE in our stratified analysesshown in Table 3 and Figure 3. It appears that increased
arterial stiffness did contribute (Fig. 3B, Table 3). Several
recent studies identified a relationship between increased
aortic stiffness and LV function (5,13,26). Abnormal vas-
cular stiffness increases LV afterload (27,28) and stimulates
LV hypertrophy (29), both factors that may decrease LVSV
ed Pulmonary Edema)
k stress aortic distensibility (y-axis) (B) measured during dobutamine cardiovas-
shown on the x-axis. In participants with isolated pulmonary edema and no
ine stress testing, left ventricular stroke volume reserve was decreased and
ots, lines within boxes represent median values; the top and bottom lines of
m whiskers outside the boxes represent the smallest data value that is 1 to
terquartile range), respectively.solat
nd pea
ps are
butam
ese pl
botto
tile (induring stress (5), respectively, by decreasing LV ejection
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reported an association of abnormal dobutamine-induced
parameters of LV diastolic function and heart failure in the
setting of a preserved LVEF. Similar to the associations that
we observed with impaired LVSV reserve and future PE,
our data show that patients in whom PE developed dis-
played increased stress/rest ratios of vascular stiffness and
increased stress distensibility measures compared with pa-
tients in whom PE did not develop.
Study limitations. First, our design, similar to a case-
control study, may not readily identify a variable in the study
population that could influence our primary outcomes of
LVSV reserve or cardiovascular stiffness. To this end, we
matched our “control” population to include those of similar
age, sex, and LVEF to our study (or case) population. In
addition, we performed multivariable analyses that ac-
counted for other clinical variables such as hypertension and
diabetes that could influence the study results. Importantly,
after accounting for these covariables, LVSV reserve and
vascular stiffness remained associated with future PE.
Second, although our DCMR method of biplane LV
volume analysis is similar to that used during dobutamine
stress echocardiography, newer 3-dimensional techniques
can measure LV volumes more accurately and in future
studies decrease potential variance in volume-derived mea-
sures. Third, our measures of vascular stiffness and aortic
distensibility incorporated brachial rather than central aortic
PP assessments. It has been shown in some individuals that
the brachial cuff pressure estimate of central aortic pressure
may not accurately reflect central aortic pressure in those
with stiff aortas or increasing heart rates (31,32). Although
large patient studies, such as the MESA (Multiethnic Study
of Atherosclerosis) (33) and the Dallas Heart Study (34)
have used aortic distensibility as an outcome measure in
3,000 participants, other techniques, such as pulse wave
velocity, are less dependent on brachial PP assessments.
Fourth, our retrospective review of hospital records may
have inadvertently omitted episodes of PE managed by
physicians using oral (rather than intravenous) diuretics in
an outpatient office setting. Other study designs could be
implemented to capture these types of events and determine
the association of PE with our measures of ventriculovas-
cular stiffness. Finally, we wish to recognize that our
stratified analyses were performed on relatively small sam-
ples, and there may be other variables, in addition to our
measures of ventriculovascular stiffness, that could be sig-
nificantly associated with further PE events.
Conclusions
Impaired LVSV reserve measured during dobutamine-
induced cardiac stress may predict an episode of future PE.
Increased arterial stiffness may impair LVSV augmentation
during stress and therefore serve as a mechanism to induce
PE in the absence of inducible LV wall motion abnormal-
ities indicative of ischemia. As a result, stress-inducedchanges in LVSV and vascular stiffness measured during
noninvasive stress testing may identify those at risk of
future PE.
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